Temasek led a $100m Series C round in Pivot Bio.

Singapore’s sovereign fund Temasek Holdings and Breakthrough Energy Ventures, led a $100m Series C funding round in Pivot Bio, a developer of microbial nitrogen tech for boosting crop yields. Other investors in the round include Prelude Ventures, Spruce Capital Partners, Codon Capital, Bunge Ventures, Continental Grain Company, Tekfen Ventures, Pavilion Capital, and individual investors Alan Cohen and Roger Underwood. “The strong backing by our Series C investors enables Pivot Bio to redefine the future of fertilizer and provide the world’s farmers with a new nitrogen source. Based on remarkable demand, we expect to ramp up from our large current footprint to millions of additional acres in the next growing season,” Karsten Temme, Pivot Bio CEO.